- Home
- EAD vs MRK Comparison
EAD vs MRK Comparison
Compare EAD & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EAD | MRK |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.7M | 268.7B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | EAD | MRK |
|---|---|---|
| Price | $6.59 | $111.85 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $125.59 |
| AVG Volume (30 Days) | 205.2K | ★ 7.3M |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 8.91% | 2.97% |
| EPS Growth | N/A | ★ 8.01 |
| EPS | N/A | ★ 7.28 |
| Revenue | N/A | ★ $65,011,000,000.00 |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | N/A | $5.41 |
| P/E Ratio | ★ N/A | $15.78 |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | $6.24 | $75.40 |
| 52 Week High | $7.18 | $125.14 |
Technical Indicators
Market Signals| Indicator | EAD | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 47.30 | 37.97 |
| Support Level | $6.52 | $105.23 |
| Resistance Level | $6.89 | $112.44 |
| Average True Range (ATR) | 0.06 | 2.99 |
| MACD | 0.01 | -0.95 |
| Stochastic Oscillator | 44.83 | 2.80 |
Price Performance
Historical ComparisonAbout EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).